Skip to main content
OpenTrials

Clinical trial condition

Refractory Acute Lymphoblastic Leukemia

Explore clinical trials studying Refractory Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

39 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Refractory Acute Lymphoblastic Leukemia trial results

Completed

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

NCT02220985

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, +57 more
Locations
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

NCT04139434

Conditions
AML/MDS, CMML, Disease Attributes, +20 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • Ohio State Comprehensive Cancer Center Columbus, Ohio, United States
  • MD Anderson Cancer Center Huston, Texas, United States
View Trial Details

Related conditions